Unique ID issued by UMIN | UMIN000017131 |
---|---|
Receipt number | R000019868 |
Scientific Title | Regulated Optical coherence tomography Follow-ups for Thrombus Evaluation-01 (ROUTE-01) study |
Date of disclosure of the study information | 2015/04/14 |
Last modified on | 2019/05/07 10:49:55 |
Regulated Optical coherence tomography Follow-ups for Thrombus Evaluation-01 (ROUTE-01) study
ROUTE-01 study
Regulated Optical coherence tomography Follow-ups for Thrombus Evaluation-01 (ROUTE-01) study
ROUTE-01 study
Japan |
patients with coronary artery disease referred for PCI under treatment with prasugrel 3.75mg/day
Cardiology |
Others
YES
To investigate the association among the frequency of in-stent thrombus, phenotype of CYP2C19 and the ability of platelet aggregation.
To assess the impact of phenotype of CYP2C19 and ability of platelet aggregation on major adverse cardiovascular events and bleeding complications.
Safety,Efficacy
the frequency of in-stent thrombus assessed by follow-up OCT 9 months after stent implantation
NIT and % of uncovered stent struts assessed by follow-up OCT 9 months after stent implantation
Major adverse cardiovascular and cerebral events (MACCE)
Bleeding complications
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
NO
1
Diagnosis
Medicine | Device,equipment |
Optical coherence tomography (OCT) was performed for the stented vessel at index PCI and 9 months after stent implantation under prescription of prasugrel
20 | years-old | <= |
90 | years-old | >= |
Male and Female
patients with coronary artery disease (including ACS) referred for PCI under treatment with prasugrel 3.75mg/day
1.patient treated with warfarin or novel oral anticoagulants (NOAC)
2.patient treated with other antiplatelet therapy
3.planning an invasive treatment with high bleeding risk
4.contraindication of aspirin or prasugrel
250
1st name | Kenichi |
Middle name | |
Last name | Hirata |
Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine, Department of Internal Medicine
6500017
7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 6500017, JAPAN
078-382-5111
hiratak@med.kobe-u.ac.jp
1st name | Toshiro |
Middle name | |
Last name | Shinke |
Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine, Department of Internal Medicine
6500017
7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 6500017, JAPAN
078-382-5111
shinke@med-showa-u.ac.jp
Kobe University Graduate School of Medicine, Division of Cardiovascular Medicine, Department of Internal Medicine
DAIICHI SANKYO COMPANY, LIMITED
Profit organization
Kobe University Hospital Clinical and Translational Research Center
7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 6500017, JAPAN
078-382-6669
chiken@med.kobe-u.ac.jp
NO
2015 | Year | 04 | Month | 14 | Day |
Partially published
250
Main results already published
2015 | Year | 03 | Month | 19 | Day |
2015 | Year | 06 | Month | 12 | Day |
2015 | Year | 10 | Month | 17 | Day |
2018 | Year | 12 | Month | 25 | Day |
2019 | Year | 03 | Month | 14 | Day |
2019 | Year | 03 | Month | 27 | Day |
2019 | Year | 06 | Month | 30 | Day |
1.OCT analysis before and after PCI
2.antiplatelet aggregation test and examination of phenotype of CYP2C19 at PCI procedure
3.OCT analysis and antiplatelet aggregation test 9 months after stent implantation
4.clinical follow-up (MACCE and bleeding complication) from stent implantation and 15 months after stent implantation
2015 | Year | 04 | Month | 14 | Day |
2019 | Year | 05 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019868